Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of an homologous recombination deficiency scoring algorithm for unmatched ovarian tumor sample based on next-generation sequencing.

Journal of gynecologic oncology·2026
Same author

The interpretable multimodal dimension reduction framework SpaHDmap enhances resolution in spatial transcriptomics.

Nature cell biology·2026
Same author

SQLE drives bladder cancer progression by boosting mitochondrial oxidative phosphorylation.

Oncogene·2025
Same author

CD160 dictates anti-PD-1 immunotherapy resistance by regulating CD8<sup>+</sup> T cell exhaustion in colorectal cancer.

Nature cell biology·2025
Same author

A New Orthotopic Mouse Model of Laryngeal Squamous Cell Carcinoma.

Head & neck·2025
Same author

Extratumoral Signs of Malignant Nonspiculate and Noncalcified Masses on Mammography: Are They Associated With Prognostic Factors in Breast Cancer?

The breast journal·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 9, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Radiopathomic Graph Deep Learning for Multiscale Spatial-Contextual Modeling of Intratumoral Heterogeneity to Predict

Liang-Qin Zhou1, Xin-Yi Wang1, Ye Xu1

  • 1Imaging Center, Harbin Medical University Cancer Hospital, Haping Rd No. 150, Nangang District, Harbin 150081, China.

Radiology. Artificial Intelligence
|April 8, 2026
PubMed
Summary
This summary is machine-generated.

A novel radio-pathomic graph deep-learning system accurately predicts breast cancer treatment response. This explainable AI integrates imaging and pathology data for improved prediction of pathologic complete response to neoadjuvant therapy.

Keywords:
BreastDynamic Contrast-enhanced MRIPerceptionPrincipal Component AnalysisPrognosisRadiology-Pathology IntegrationReconstruction AlgorithmSupervised LearningTumor Response

More Related Videos

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

23.5K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.7K

Related Experiment Videos

Last Updated: Apr 9, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

23.5K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.7K

Area of Science:

  • Oncology
  • Radiology
  • Pathology
  • Artificial Intelligence
  • Deep Learning

Background:

  • Intratumoral heterogeneity (ITH) significantly impacts breast cancer (BC) treatment response.
  • Predicting pathologic complete response (pCR) to neoadjuvant therapy (NAT) is crucial for personalized BC treatment.
  • Current prediction methods may not fully capture the complex spatial-contextual information within tumors.

Purpose of the Study:

  • To develop an explainable radio-pathomic graph deep-learning (RPGDL) system for multiscale spatial-contextual modeling of ITH.
  • To evaluate the RPGDL system's performance in predicting pCR to NAT in breast cancer.
  • To enhance the interpretability of deep learning models in predicting treatment outcomes.

Main Methods:

  • A retrospective dual-center analysis of invasive BC patients (N=1050) using pretherapeutic MRI and H&E-stained biopsy slides.
  • Generation of individual radiomic and pathomic graphs from imaging and pathology data, respectively.
  • Development and application of three distinct graph neural networks (GNNs): radiomic, pathomic, and radio-pathomic GNNs, with performance assessed using AUC, NRI, and IDI.

Main Results:

  • The integrated radio-pathomic GNN achieved superior performance (AUC 0.95 training, 0.91 external test) compared to single-modality GNNs (radiomic AUC 0.89/0.84, pathomic AUC 0.87/0.83).
  • Pathomic graphs were key drivers for predicting pCR, while radiomic graphs influenced predictions for non-pCR.
  • Multifaceted analyses confirmed the explainability of the GNNs' predictions.

Conclusions:

  • The developed RPGDL system effectively models multiscale spatial-contextual ITH.
  • The RPGDL system provides high-performance and explainable prediction of pCR to NAT in breast cancer.
  • This approach offers a promising tool for personalized treatment strategies in breast cancer.